Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


The present invention provides vaccine compositions of attenuated dengue-4 virus. More specifically, the attenuated virus is produced by serial passage in PDK cells. The invention also provides methods for stimulating the immune system of an individual to induce protection against dengue-4 virus by administration of attenuated dengue-4 virus.

Docket:WRAIR 98-50

Publication/Issued No.:6,537,557

Publication/Issue Date:2003-03-25

Categories: Vaccine

More Detail:Visit USPTO.GOVExternal link


Inventor(s):ECKELS, ET AL

For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 25 Jul 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736.